GEODE CAPITAL MANAGEMENT, LLC - ARIDIS PHARMACEUTICALS INC ownership

ARIDIS PHARMACEUTICALS INC's ticker is ARDS and the CUSIP is 040334104. A total of 17 filers reported holding ARIDIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of ARIDIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$31,453
-30.0%
143,0340.0%0.00%
Q1 2023$44,926
+26641.7%
143,0340.0%0.00%
Q4 2022$168
-99.9%
143,034
+5.2%
0.00%
Q3 2022$126,000
+4.1%
136,021
+23.4%
0.00%
Q2 2022$121,000
-35.3%
110,200
+3.3%
0.00%
Q1 2022$187,000
+112.5%
106,639
+180.8%
0.00%
Q4 2021$88,000
-33.3%
37,974
+5.8%
0.00%
Q3 2021$132,00035,8990.00%
Other shareholders
ARIDIS PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 272,886$2,019,0002.36%
AIGH Capital Management LLC 459,261$3,331,0000.60%
Worth Venture Partners, LLC 105,413$780,0000.29%
PERRITT CAPITAL MANAGEMENT INC 16,000$118,0000.06%
Minot Wealth Management LLC 25,000$152,0000.03%
Newbridge Financial Services Group, Inc. 400$3,0000.00%
UBS Group AG 3,229$24,0000.00%
WELLS FARGO & COMPANY/MN 1,271$9,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
CITIGROUP INC 750$6,0000.00%
View complete list of ARIDIS PHARMACEUTICALS INC shareholders